Board of Directors

Astra Zeneca / WHA 2018 / Genf / Intercontinental Geneve / 20. bis 22.Mai 2018 / Portrait Helen-Marie SeibelHelen-Marie Seibel

Helen has two decades of experience developing impactful corporate citizenship programming.  She is a galvanizing leader who works across sectors and organisations to drive meaningful change and address complex social issues.  From strategic development to hands on programme delivery, Helen has worked in the areas of partnership development, stakeholder engagement and management, measurement and evaluation, volunteerism, and employee engagement.  In 2013, Helen was invited to use this experience to develop a CSR course at Ryerson University in Toronto, Canada which she teaches as part of the Chang School of Continuing Education.  Helen currently leads Global Community Investment for AstraZeneca, addressing global health challenges with a specific focus on disease prevention and adolescent health.

samira_head1Samira Zia Rehman

Samira is a seasoned media and communications professional having worked in both the public and private sector. Her career has largely focused on arts, culture and entertainment with a strong emphasis on community building.  She is a passionate storyteller with key strengths in issues management, creative direction, and strategic planning. Samira is dedicated to representing under-served communities and creating the capacity for others to meet their full potential through art and mentorship. She is also an unwavering advocate for women’s rights and safety, volunteering and fundraising for over ten years for various agencies including Aids Committee of Toronto, Toronto Rape Crisis Centre and women’s shelters throughout the GTA.

dr-ellen-warner-Dr. Ellen Warner

Dr. Warner is a professor of medicine at the University of Toronto and a staff medical oncologist at the Odette Cancer Centre at Sunnybrook since 1993. Her practice and research are devoted to breast cancer. In 1994, she created a program for hereditary breast and ovarian cancer patients, which introduced genetic counselling and testing to the Odette Cancer Centre. Since 1997 she has led a study to explore the role of MRI in screening women with an inherited predisposition to develop breast cancer. This research helped make annual MRI surveillance the standard of care for this very high-risk population and led to the development of the high-risk Ontario breast screening program. Since 2011 the program has offered annual MRI and mammography to women at very high risk for breast cancer between ages 30 and 70.

In addition, Dr. Warner is the creator and director of PYNK: Breast Cancer Program for Young Women. Launched in 2008, it is the only interdisciplinary clinical and research program in Canada for breast cancer patients diagnosed at age 40 or younger. PYNK addresses the special medical and psychosocial needs of this population and offers these women enrolment in studies focusing on women in this age group.

maryMary Minna

Mary Minna is a retired Accountant.  Mary graduated in Bachelor of Business Management from Ryerson University.  Mary also attained her CPA designation in 1983.  Mary worked for Suncor Energy Inc for 35 years in various accounting roles and left in 2015 as Manager of Inventory Accounting.